These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [In vitro activity of beta-lactam agents and beta-lactamase inhibitors in clinical isolates of Acinetobacter baumannii]. López-Hernández S, Alarcón T, Delgado T, de Las Cuevas MC, López-Brea M. Rev Esp Quimioter; 1999 Jun; 12(2):140-3. PubMed ID: 10562675 [Abstract] [Full Text] [Related]
43. In vitro study to compare sensitivity of amoxicillin+clavulanic acid and cefpodoxime+clavulanic acid among beta-lactamase positive clinical isolates of gram-positive and gram-negative pathogens. Pal RB, Pal P, Jain S, Kulkarni KP. J Indian Med Assoc; 2008 Aug; 106(8):545-8. PubMed ID: 18975519 [Abstract] [Full Text] [Related]
45. In vitro assessment of the effect of clavulanic acid at concentrations achieved in human serum on the bactericidal activity of amoxicillin at physiological concentrations against Staphylococcus aureus: implications for dosage regimens. Aguilar L, Martín M, Balcabao IP, Gómez-Lus ML, Dal-Ré R, Prieto J. Antimicrob Agents Chemother; 1997 Jun; 41(6):1403-5. PubMed ID: 9174210 [Abstract] [Full Text] [Related]
49. N-thiolated beta-lactams: a new family of anti-Bacillus agents. Turos E, Long TE, Heldreth B, Leslie JM, Reddy GS, Wang Y, Coates C, Konaklieva M, Dickey S, Lim DV, Alonso E, Gonzalez J. Bioorg Med Chem Lett; 2006 Apr 15; 16(8):2084-90. PubMed ID: 16473509 [Abstract] [Full Text] [Related]
51. Synthesis and SAR of novel benzoxaboroles as a new class of β-lactamase inhibitors. Xia Y, Cao K, Zhou Y, Alley MR, Rock F, Mohan M, Meewan M, Baker SJ, Lux S, Ding CZ, Jia G, Kully M, Plattner JJ. Bioorg Med Chem Lett; 2011 Apr 15; 21(8):2533-6. PubMed ID: 21392987 [Abstract] [Full Text] [Related]